In this issue: Aspirin and cancer prevention; rivaroxaban for pulmonary embolism; new rhinosinusitis practice guidelines; and FDA actions.
This study from Portugal addresses an important gap in managing patients who have been extubated after an episode of acute respiratory failure facilitating the clearance of airway secretions to avoid the necessity of reintubation.
The purpose of this study was to use data from the multi-institutional APACHE IV database (Cerner Corporation) to compare characteristics of and outcomes for patients who were readmitted to the ICU and those who were not readmitted after ICU discharge; to identify risk factors for ICU readmission; and to examine case-mix adjusted outcomes for patients with and without ICU readmission.
In patients with severe coronary artery disease (CAD) and depressed left ventricular (LV) function, coronary artery bypass graft (CABG) surgery remains the recommended treatment.
Beta-blockers have long been a cornerstone of therapy for patients who have suffered myocardial infarction (MI). However, most studies of beta blockade following MI were performed before the current era of reperfusion therapy, statins, and antiplatelet agents.
This paper reports the results of the Safety of Two Strategies of ICD Management at Implantation (SAFE-ICD) study.
Dementia and benzodiazepines; effectiveness of omega-3 fatty acid and Ginkgo biloba supplements; and FDA actions.
